Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment.
Hunger
Robert E
RE
Hunziker
Thomas
T
Buettiker
Urs
U
Braathen
Lasse R
LR
Yawalkar
Nikhil
N
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004008:Diclofenac / Q000009:adverse effects; D005260:Female; D006801:Humans; D000069285:Infliximab; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012867:Skin / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D013262:Stevens-Johnson Syndrome / Q000235:genetics / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D004008:Diclofenac; D000069285:Infliximab